CRIP2 and breast carcinoma: We previously reported that higher CRP2 expression is correlated with significantly shorter overall and distant metastasis-free survival (OS and DMFS, respectively) in basal-like breast cancer (Hoffmann et al., 2016; Hoffmann et al., 2018), a molecular subtype of breast cancer with aggressive behavior and in which CRP2 is upregulated (Hu et al., 2006; Hoffmann et al., 2016).